feed,title,long_url,short_url
MarketWatch,Halozyme Therapeutics started at buy with $39 stock price target at Benchmark,http://feeds.marketwatch.com/~r/marketwatch/realtimeheadlines/~3/nb_BkRpIfXs/quotes.asp,https://j.mp/2VzY6tA
